Censured Indian Plant Gets USFDA Nod to Supply Trump-Touted Drug
A technician cultivates lung cells as he preps for research into the infectivity of the SARS-CoV-2 in human lungs at a laboratory at the University of Hong Kong in Hong Kong, China. (Photographer: Paul Yeung/Bloomberg)

Censured Indian Plant Gets USFDA Nod to Supply Trump-Touted Drug

(Bloomberg) -- U.S. regulators have lifted import restrictions on an Indian pharmaceutical company in an effort to increase supplies of a malaria drug touted by President Donald Trump as a potentia...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.